These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2839213)

  • 1. Natural history of hepatocellular carcinoma as viewed by the pathologist.
    Callea F
    Appl Pathol; 1988; 6(2):105-16. PubMed ID: 2839213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological diagnosis of hepatocellular carcinoma.
    Callea F; Fabbretti G; Brisigotti M; Cozzutto C
    Ital J Gastroenterol; 1992 Jan; 24(1):50-4. PubMed ID: 1373976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
    Herrmann G
    Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha 1-Antitrypsin deficiency and hepatocellular carcinoma. Association with cirrhosis, copper storage, and Mallory bodies.
    Rubel LR; Ishak KG; Benjamin SB; Knuff TE
    Arch Pathol Lab Med; 1982 Dec; 106(13):678-81. PubMed ID: 6291490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
    Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C; Licht J; Roessner A; Carl-McGrath S
    J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma.
    Cantaboni A; Sironi M; Taccagni GL; Ferrari AM
    Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic neoductules].
    Fischer HP; Meybehm M; Zhou H; Schoch J
    Verh Dtsch Ges Pathol; 1995; 79():36-46. PubMed ID: 8600693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical staining of fine-needle aspiration biopsies of the liver as a diagnostic tool for hepatocellular carcinoma.
    Johnson DE; Powers CN; Rupp G; Frable WJ
    Mod Pathol; 1992 Mar; 5(2):117-23. PubMed ID: 1374187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of hepatocellular carcinoma.
    Callea F; Favret M; Marino C; Brisigotti M
    J Surg Oncol Suppl; 1993; 3():168-9. PubMed ID: 8389164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of alpha-1-antitrypsin and alpha-1-antichymotrypsin in hepatocellular carcinoma: an immunoperoxidase study.
    Ordóñez NG; Manning JT
    Am J Gastroenterol; 1984 Dec; 79(12):959-63. PubMed ID: 6095653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.